Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD | Director | 26 | $7.28M | $5.90M | 2017-03-08 |
| Bluth John D | EVP of Investor Relations | 5 | $0 | $0 | 2017-02-23 |
| Oldach David W. | Chief Medical Officer | 15 | $0 | $653.8K | 2017-02-23 |
| Moore David | Chief Commercial Officer | 8 | $8.1K | $0 | 2017-02-23 |
| Hahn Mark W | EVP and CFO | 10 | $0 | $0 | 2017-02-23 |
| Kong Garheng | Director | 7 | $49.3K | $0 | 2017-01-03 |
| JOHNSON JOHN | Director | 7 | $91.0K | $0 | 2017-01-03 |
| Kent Richard S | Director | 10 | $0 | $0 | 2017-01-03 |
| GILL DAVID N | Director | 7 | $14.7K | $0 | 2017-01-03 |
| DOUGHERTY MICHAEL R | Director | 6 | $36.9K | $0 | 2017-01-03 |
| ZACCARDELLI DAVID | Director | 3 | $0 | $0 | 2016-12-09 |
| NEFF P SHERRILL | Director, 10% Owner | 9 | $8.99M | $0 | 2016-10-05 |
| Fernandes Prabhavathi | President and CEO | 17 | $30.1K | $321.5K | 2016-01-01 |
| Mumma Mitch | 10% Owner | 6 | $0 | $0 | 2015-08-18 |
| Quaker BioVentures II LP | 10% Owner | 1 | $1.85M | $0 | 2013-06-19 |
| MORRIS I WISTAR III | Director, 10% Owner | 11 | $424.6K | $0 | 2012-08-17 |
| Dougherty Dennis | 10% Owner | 2 | $7.33M | $0 | 2012-02-08 |
| Purcell Dennis J | 10% Owner | 1 | $7.28M | $0 | 2012-02-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD | Director | S Sale | 2017-03-08 | 2017-03-09 | 99,900 | $3.57 | $356.6K | 0 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | S Sale | 2017-03-07 | 2017-03-09 | 50,100 | $3.53 | $176.9K | 99,900 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Bluth John D | EVP of IR and Corp Comm | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Bluth John D | EVP of IR and Corp Comm | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Oldach David W. | Chief Medical Officer | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Oldach David W. | Chief Medical Officer | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | S Sale | 2017-01-13 | 2017-01-18 | 105,460 | $3.40 | $358.6K | 150,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | S Sale | 2017-01-06 | 2017-01-06 | 437,600 | $3.64 | $1.59M | 255,460 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | S Sale | 2017-01-05 | 2017-01-06 | 500,000 | $3.20 | $1.60M | 693,060 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2017-01-03 | 2017-01-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award deriv | 2017-01-03 | 2017-01-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Oldach David W. | Chief Medical Officer | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Oldach David W. | Chief Medical Officer | A Award deriv | 2017-01-03 | 2017-01-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Bluth John D | EVP of Investor Relations | A Award deriv | 2017-01-03 | 2017-01-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Bluth John D | EVP of Investor Relations | A Award deriv | 2017-01-03 | 2017-01-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2017-01-03 | 2017-01-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2017-01-03 | 2017-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kent Richard S | Director | A Award deriv | 2017-01-03 | 2017-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GILL DAVID N | Director | A Award deriv | 2017-01-03 | 2017-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2017-01-03 | 2017-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2017-01-03 | 2017-02-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GILL DAVID N | Director | P Buy | 2017-01-03 | 2017-01-04 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| ZACCARDELLI DAVID | Acting Chief Executive Offic | A Award deriv | 2016-12-09 | 2016-12-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ZACCARDELLI DAVID | Acting Chief Executive Offic | A Award deriv | 2016-12-09 | 2016-12-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NEFF P SHERRILL | Director | J Other | 2016-10-05 | 2016-10-07 | 2,488 | — | $0 | 2,488 | SEC↗ |
| NEFF P SHERRILL | Director | J Other | 2016-10-05 | 2016-10-07 | 1,000,000 | — | $0 | 2,527,154 | SEC↗ |
| ZACCARDELLI DAVID | Director | A Award deriv | 2016-08-10 | 2016-08-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Bluth John D | EVP of Investor Relations | A Award deriv | 2016-08-05 | 2016-08-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | J Other | 2016-03-07 | 2016-03-09 | 999,955 | — | $0 | 1,193,060 | SEC↗ |
| Moore David | Chief Commercial Officer | P Buy | 2016-03-01 | 2016-03-02 | 500 | $16.18 | $8.1K | 1,500 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | S Sale | 2016-01-04 | 2016-01-06 | 842 | $30.06 | $25.3K | 50 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise | 2016-01-04 | 2016-01-06 | 842 | — | $0 | 892 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2016-01-01 | 2016-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2016-01-01 | 2016-01-05 | 183,570 | — | $0 | 183,570 | SEC↗ |
| GILL DAVID N | Director | A Award deriv | 2016-01-01 | 2016-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2016-01-01 | 2016-01-05 | 59,660 | — | $0 | 59,660 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2016-01-01 | 2016-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kent Richard S | Director | A Award deriv | 2016-01-01 | 2016-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2016-01-01 | 2016-01-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award deriv | 2016-01-01 | 2016-01-05 | 59,660 | — | $0 | 59,660 | SEC↗ |
| NEFF P SHERRILL | Director | A Award deriv | 2016-01-01 | 2016-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Oldach David W. | Chief Medical Officer | A Award deriv | 2016-01-01 | 2016-01-05 | 45,893 | — | $0 | 45,893 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2016-01-01 | 2016-01-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Oldach David W. | Chief Medical Officer | M Exercise deriv | 2015-12-15 | 2015-12-15 | 1,778 | — | $0 | 16,347 | SEC↗ |
| Oldach David W. | Chief Medical Officer | S Sale | 2015-12-15 | 2015-12-15 | 1,778 | $30.00 | $53.3K | 1,100 | SEC↗ |
| Oldach David W. | Chief Medical Officer | M Exercise | 2015-12-15 | 2015-12-15 | 1,778 | $2.28 | $4.1K | 2,878 | SEC↗ |
| Oldach David W. | Chief Medical Officer | M Exercise deriv | 2015-12-11 | 2015-12-15 | 8,222 | — | $0 | 18,125 | SEC↗ |
| Oldach David W. | Chief Medical Officer | M Exercise | 2015-12-11 | 2015-12-15 | 8,222 | $2.28 | $18.7K | 9,322 | SEC↗ |
| Oldach David W. | Chief Medical Officer | S Sale | 2015-12-11 | 2015-12-15 | 8,222 | $30.33 | $249.4K | 1,100 | SEC↗ |
| Oldach David W. | Chief Medical Officer | M Exercise deriv | 2015-11-09 | 2015-11-12 | 10,000 | — | $0 | 26,347 | SEC↗ |
| Oldach David W. | Chief Medical Officer | S Sale | 2015-11-09 | 2015-11-12 | 10,000 | $28.78 | $287.8K | 3,300 | SEC↗ |
| Oldach David W. | Chief Medical Officer | S Sale | 2015-11-09 | 2015-11-12 | 2,200 | $28.78 | $63.3K | 1,100 | SEC↗ |
| Oldach David W. | Chief Medical Officer | M Exercise | 2015-11-09 | 2015-11-12 | 10,000 | $2.28 | $22.8K | 13,300 | SEC↗ |
| Kong Garheng | Director | P Buy | 2015-10-26 | 2015-10-26 | 2,830 | $17.43 | $49.3K | 2,830 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | P Buy | 2015-10-26 | 2015-10-27 | 2,000 | $18.45 | $36.9K | 2,000 | SEC↗ |
| Mumma Mitch | 10% Owner | M Exercise deriv | 2015-08-18 | 2016-03-03 | 23,686 | — | $0 | 0 | SEC↗ |
| Mumma Mitch | 10% Owner | M Exercise deriv | 2015-08-18 | 2016-03-03 | 15,790 | — | $0 | 0 | SEC↗ |
| Mumma Mitch | 10% Owner | M Exercise | 2015-08-18 | 2016-03-03 | 15,790 | $6.00 | $94.7K | 1,392,261 | SEC↗ |
| Mumma Mitch | 10% Owner | M Exercise | 2015-08-18 | 2016-03-03 | 23,686 | $6.00 | $142.1K | 963,502 | SEC↗ |
| Mumma Mitch | 10% Owner | J Other | 2015-08-06 | 2016-03-03 | 594,258 | — | $0 | 1,376,471 | SEC↗ |
| Mumma Mitch | 10% Owner | J Other | 2015-08-06 | 2016-03-03 | 405,742 | — | $0 | 939,816 | SEC↗ |
| Kent Richard S | Director | J Other | 2015-08-06 | 2015-08-14 | 324 | — | $0 | 392 | SEC↗ |
| Kent Richard S | Director | J Other | 2015-08-06 | 2015-08-14 | 68 | — | $0 | 68 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise deriv | 2015-06-22 | 2016-01-06 | 842 | — | $0 | 9,158 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise deriv | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise deriv | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise deriv | 2015-06-22 | 2015-06-24 | 5,000 | — | $0 | 10,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise deriv | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | S Sale | 2015-06-22 | 2015-06-24 | 50,000 | $35.74 | $1.79M | 50 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 35,050 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 20,050 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise | 2015-06-22 | 2015-06-24 | 5,000 | — | $0 | 5,050 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 50,050 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise deriv | 2015-05-22 | 2015-05-27 | 13,123 | — | $0 | 86,877 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise deriv | 2015-05-22 | 2015-05-27 | 9,000 | — | $0 | 73,194 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise deriv | 2015-05-22 | 2015-05-27 | 15,266 | — | $0 | 109,734 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise | 2015-05-22 | 2015-05-27 | 9,000 | $2.09 | $18.8K | 256,678 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise | 2015-05-22 | 2015-05-27 | 13,123 | $7.62 | $100.0K | 232,412 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | S Sale | 2015-05-22 | 2015-05-27 | 9,000 | $35.72 | $321.5K | 247,678 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise | 2015-05-22 | 2015-05-27 | 15,266 | $13.10 | $200.0K | 247,678 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | J Other | 2015-05-14 | 2015-05-18 | 1,099,950 | — | $0 | 2,193,110 | SEC↗ |
| Kent Richard S | Director | M Exercise deriv | 2015-03-04 | 2016-10-20 | 15,000 | — | $0 | 0 | SEC↗ |
| Kent Richard S | Director | M Exercise | 2015-03-04 | 2016-10-20 | 15,000 | $13.10 | $196.5K | 15,392 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award | 2015-03-04 | 2015-03-06 | 1,000 | $32.59 | $32.6K | 1,000 | SEC↗ |
| GILL DAVID N | Director | A Award deriv | 2015-01-01 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2015-01-01 | 2015-01-02 | 133,499 | — | $0 | 133,499 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2015-01-01 | 2015-01-02 | 18,000 | — | $0 | 18,000 | SEC↗ |
| NEFF P SHERRILL | Director | A Award deriv | 2015-01-01 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Moore David | Chief Commercial Officer | A Award deriv | 2015-01-01 | 2015-01-02 | 36,363 | — | $0 | 36,363 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2015-01-01 | 2015-01-02 | 46,363 | — | $0 | 46,363 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2015-01-01 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kent Richard S | Director | A Award deriv | 2015-01-01 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2015-01-01 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2015-01-01 | 2015-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| JOHNSON JOHN | Director | P Buy | 2014-05-23 | 2014-05-28 | 10,000 | $9.10 | $91.0K | 10,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise deriv | 2014-05-14 | 2014-05-15 | 12,105 | — | $0 | 0 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | M Exercise | 2014-05-14 | 2014-05-15 | 12,105 | $1.43 | $17.3K | 219,289 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2014-01-08 | 2014-01-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NEFF P SHERRILL | Director | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GILL DAVID N | Director | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2014-01-08 | 2014-01-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kent Richard S | Director | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2014-01-08 | 2014-01-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2014-01-08 | 2014-01-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2014-01-08 | 2014-01-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Quaker BioVentures II LP | 10% Owner | P Buy | 2013-06-19 | 2013-08-01 | 265,000 | $7.00 | $1.85M | 3,527,154 | SEC↗ |
| NEFF P SHERRILL | Director | P Buy | 2013-06-19 | 2013-08-01 | 265,000 | $7.00 | $1.85M | 3,527,154 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2013-06-03 | 2013-06-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | P Buy | 2013-05-09 | 2014-05-13 | 3,500 | $8.60 | $30.1K | 207,184 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2013-03-07 | 2013-03-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2013-02-04 | 2013-02-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GILL DAVID N | Director | A Award deriv | 2013-02-04 | 2013-02-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2013-02-04 | 2013-02-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kent Richard S | Director | A Award deriv | 2013-02-04 | 2013-02-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2013-02-04 | 2013-02-06 | 18,000 | — | $0 | 18,000 | SEC↗ |
| NEFF P SHERRILL | Director | A Award deriv | 2013-02-04 | 2013-02-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2013-01-18 | 2013-01-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2013-01-18 | 2013-01-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | M Exercise deriv | 2012-08-17 | 2012-08-21 | 2,500 | $7.62 | $19.1K | 12,500 | SEC↗ |
| MORRIS I WISTAR III | 10% Owner | M Exercise | 2012-08-17 | 2012-08-21 | 2,500 | $7.62 | $19.1K | 744,533 | SEC↗ |
| GILL DAVID N | Director | A Award deriv | 2012-04-02 | 2012-04-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kent Richard S | Director | A Award deriv | 2012-03-20 | 2012-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Fernandes Prabhavathi | President and CEO | A Award deriv | 2012-03-20 | 2012-03-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hahn Mark W | EVP and CFO | A Award deriv | 2012-03-20 | 2012-03-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kong Garheng | Director | A Award deriv | 2012-03-20 | 2012-03-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| JOHNSON JOHN | Director | A Award deriv | 2012-03-20 | 2012-03-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | A Award deriv | 2012-03-20 | 2012-03-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NEFF P SHERRILL | Director | A Award deriv | 2012-03-20 | 2012-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2012-03-20 | 2012-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NEFF P SHERRILL | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-09 | 1,189,805 | $6.00 | $7.14M | 3,262,154 | SEC↗ |
| Dougherty Dennis | 10% Owner | P Buy | 2012-02-08 | 2012-02-09 | 488,659 | $6.00 | $2.93M | 1,970,729 | SEC↗ |
| Dougherty Dennis | 10% Owner | P Buy | 2012-02-08 | 2012-02-09 | 732,989 | $6.00 | $4.40M | 1,345,558 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 1,025 | $6.00 | $6.2K | 496,286 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 16,667 | $6.00 | $100.0K | 741,008 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 1,025 | $6.00 | $6.2K | 742,033 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 16,667 | $6.00 | $100.0K | 495,261 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 1,025 | $6.00 | $6.2K | 474,616 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 16,666 | $6.00 | $100.0K | 473,591 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 1,025 | $6.00 | $6.2K | 517,566 | SEC↗ |
| MORRIS I WISTAR III | Director, 10% Owner | P Buy | 2012-02-08 | 2012-02-10 | 16,666 | $6.00 | $100.0K | 516,541 | SEC↗ |
| Purcell Dennis J | 10% Owner | P Buy | 2012-02-07 | 2012-02-09 | 1,213,663 | $6.00 | $7.28M | 3,293,060 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | P Buy | 2012-02-07 | 2012-02-09 | 1,213,663 | $6.00 | $7.28M | 3,293,060 | SEC↗ |